• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.

作者信息

Takahashi H, Takakuwa E, Yoshino N, Hanano M, Shibata A

出版信息

Thromb Haemost. 1985 Aug 30;54(2):445-9.

PMID:3841232
Abstract

Protein C was measured by means of enzyme-linked immunosorbent assay (ELISA) in plasmas from 58 normal subjects, 39 patients with disseminated intravascular coagulation (DIC) and 5 patients with thrombotic thrombocytopenic purpura (TTP). Protein C levels ranged from 69.7 to 163.6% (95% confidence limits) in normal subjects. In patients with DIC, protein C concentrations were significantly decreased, with a geometric mean value of 42.1%. Protein C concentration was positively correlated with plasma prothrombin, antithrombin III and serum pseudocholinesterase, and was negatively correlated with von Willebrand factor antigen (vWF:Ag) and vWF:Ag/factor VIII ratio. These findings suggest that low protein C concentrations in DIC mean a consumption of protein C probably due to its activation by thrombin and/or impaired liver synthetic function. In patients with TTP, protein C levels were normal with a geometric mean value of 116.7%, indicating that the pathophysiology of TTP is quite different from that of DIC.

摘要

相似文献

1
Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
Thromb Haemost. 1985 Aug 30;54(2):445-9.
2
[Plasma level of various markers in patients with thrombotic thrombocytopenic purpura].
Rinsho Ketsueki. 1994 Apr;35(4):346-51.
3
Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.针对组织因子途径抑制物-因子Xa复合物的单克隆抗体:其特性及在弥散性血管内凝血和弥散性血管内凝血前期患者血浆中的应用
Blood Coagul Fibrinolysis. 1999 Sep;10(6):309-19.
4
Behaviour of protein C inhibitor in intravascular coagulation and liver disease.
Thromb Haemost. 1984 Aug 31;52(1):71-4.
5
Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜患者血浆组织因子途径抑制物水平降低。
Thromb Haemost. 1995 Jan;73(1):10-4.
6
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.弥散性血管内凝血或血栓性血小板减少性紫癜患者若伴有严重血管内皮细胞损伤,预后较差。
Am J Hematol. 1998 Jul;58(3):189-94. doi: 10.1002/(sici)1096-8652(199807)58:3<189::aid-ajh5>3.0.co;2-n.
7
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
8
[Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].[临床预期发生血管内凝血患者的凝血因子VIII(凝血活性VIII:C、抗原浓度VIIIR:Ag和血管性血友病因子)]
Schweiz Med Wochenschr. 1981 Oct 10;111(41):1542-3.
9
Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura.获得性血栓性血小板减少性紫癜中凝血和纤溶标志物的特征行为。
J Intensive Care Med. 2021 Apr;36(4):436-442. doi: 10.1177/0885066619899637. Epub 2020 Jan 22.
10
Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.弥散性血管内凝血(DIC)及相关疾病患者的血浆 ADAMTS13、血管性血友病因子(VWF)和 VWF 前肽谱。
Thromb Res. 2012 May;129(5):598-602. doi: 10.1016/j.thromres.2011.10.011. Epub 2011 Nov 8.

引用本文的文献

1
Prospective Application of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Disseminated Intravascular Coagulation.间充质干细胞衍生的外泌体在弥漫性血管内凝血治疗中的前瞻性应用。
Int J Nanomedicine. 2024 Nov 16;19:11957-11971. doi: 10.2147/IJN.S467158. eCollection 2024.
2
COVID-19-Associated Disseminated Intravascular Coagulopathy Presenting As Inferior ST-Segment Elevation Myocardial Infarction.表现为下壁ST段抬高型心肌梗死的新型冠状病毒肺炎相关弥散性血管内凝血
Cureus. 2023 May 21;15(5):e39308. doi: 10.7759/cureus.39308. eCollection 2023 May.
3
Hemostatic system and COVID-19 crosstalk: A review of the available evidence.
止血系统与新型冠状病毒肺炎的相互作用:现有证据综述
World J Methodol. 2022 Sep 20;12(5):331-349. doi: 10.5662/wjm.v12.i5.331.
4
Disseminated intravascular coagulation and its immune mechanisms.弥散性血管内凝血及其免疫机制。
Blood. 2022 Mar 31;139(13):1973-1986. doi: 10.1182/blood.2020007208.
5
ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.在人内皮化微流控模型中,靶向细胞间黏附分子-1的血栓调节蛋白可减轻组织因子驱动的炎症性血栓形成。
Blood Adv. 2017 Aug 8;1(18):1452-1465. doi: 10.1182/bloodadvances.2017007229.
6
Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management.急性早幼粒细胞白血病中全反式维甲酸的不良反应表现为急性冠状动脉综合征:一例报告并文献复习及治疗要点
Case Rep Oncol Med. 2016;2016:2829142. doi: 10.1155/2016/2829142. Epub 2016 Feb 11.
7
Disseminated intravascular coagulation as a possible cause of acute coronary stent thrombosis: a case report and literature review.弥散性血管内凝血作为急性冠状动脉支架血栓形成的可能原因:一例报告及文献综述
Case Rep Crit Care. 2012;2012:178260. doi: 10.1155/2012/178260. Epub 2012 Dec 17.